Announcements Trials
Browse Landscape

Phase

Phase 2 210Phase 3 63Phase 1 61Phase 1/2 43Phase 4 18Phase NA 7Phase EARLY_PHASE1 3Phase 2/3 2

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Imatinib Mesylate × Clear all
NCT05816785 2026-04-22

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

University of Wisconsin, Madison

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04006769 2023-10-18

Entacapone Combination With Imatinib for Treatment of GIST

Xiangya Hospital of Central South University

Phase EARLY_PHASE1 Completed
5 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03228303 2017-10-10

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Assiut University

Phase EARLY_PHASE1 Unknown
100 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡